Molecular Typing of Candida Albicans Isolates Recovered from Human Immunodeficiency Virus (HIV)-Infected Patients with Oropharyngeal Candidiasis

Document Type : Original Article (s)

Authors

1 Assistant Professor, Department of Pathobiology, School of Veterinary Medicine, University of Tabriz, Tabriz, Iran

2 Professor, Mycology Research Center, School of Veterinary Medicine, University of Tehran, Iran

3 Associate Professor, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran

4 Student of Veterinary, School of Veterinary Medicine, University of Tabriz, Tabriz, Iran

5 Professor, Iranian Research Center for HIV/AIDS (IRCHA), Imam Khomeini Hospital, Tehran University of Medical Sciences, Iran

Abstract

Background: In human immunodeficiency virus HIV-infected patients, oropharyngeal candidiasis is a common infection. The aim of present study was molecular typing of Candida albicans isolates recovered from HIV-infected patients with oropharyngeal candidiasis and comparing the molecular patterns of fluconazole-resistant and susceptible isolates.Methods: The molecular typing of genomic DNA of 48 Candida albicans isolated from HIV-infected patients were assessed by the random amplified polymorphic DNA-polymerase chain reaction (RAPD-PCR) fingerprinting. Sensitivity of strains to fluconazole was determined by the broth microdilution method.Findings: We detected two main clusters and seven sub-clusters, comprising 24 genotypes of Candida albicans strains. No associations between the patterns of strains isolated from hospitalized patients and outpatients and clinical forms of oropharyngeal candidiasis were detected. There was also a relative correlation between fluconazole susceptibility and strain clustering.Conclusion: The presence of several genotypes of Candida albicans in HIV-infected patients would lead to problems in the treatment and prevention of oral candidiasis. The lack of correlation between genotypes and clinical forms of oropharyngeal candidiasis shows the importance pf host condition in the pathogenesis of candida infections. The lack of phylogenetic relationships among strains from hospitalized patients approves endogenous origin of candida infection. The results indicate that HIV-infected patients have favorable conditions for the growth and proliferation of different genotypes of Candida albicans. In conclusion, molecular typing using RAPD-PCR revealed a genomic heterogeneity in the Candida albicans clinical isolates studied in HIV-infected patients.

Keywords

References

  1. Pelletier R, Peter J, Antin C, Gonzalez C, Wood L, Walsh TJ. Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations. J Clin Microbiol 2000; 38(4): 1563-8.
  2. Fidel PL, Huffnagle GB. Fungal immunology: from an organ perspective. New York, NY: Springer; 2005. p. 59-83.
  3. Morgan J. Global trends in candidemia: review of reports from 1995-2005. Curr Infect Dis Rep 2005; 7(6): 429-39.
  4. Jabra-Rizk MA, Falkler WA, Meiller TF. Fungal biofilms and drug resistance. Emerg Infect Dis 2004; 10(1): 14-9.
  5. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995; 141 ( Pt 7): 1507-21.
  6. Wade JC. Epidemiology of candida infection. In: Bodey GP, editor. Candidiasis: pathogenesis, diagnosis, and treatment. 2nd ed. New York, NY: Ravan Press; 1993. p. 85.
  7. Katiraee F, Khosravi AR, Khalaj V, Hajiabdolbaghi M, Khaksar AR, Rasoulinejad M. In vitro antifungal susceptibility of oral candida species from Iranian HIV infected patients. Tehran Univ Med J 2012; 70(2): 96-103. [In Persian].
  8. Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994; 32(8): 1923-9.
  9. Sanguinetti M, Porta R, Sali M, La SM, Pecorini G, Fadda G, et al. Evaluation of VITEK 2 and RapID yeast plus systems for yeast species identification: experience at a large clinical microbiology laboratory. J Clin Microbiol 2007; 45(4): 1343-6.
  10. Odds FC, Davidson A. "Room temperature" use of CHROMagar Candida. Diagn Microbiol Infect Dis 2000; 38(3): 147-50.
  11. Katiraee F, Khosravi AR, Khalaj V, Hajiabdolbaghi M, Khaksar A, Rasoolinejad M, et al. Oropharyngeal candidiasis and oral yeast colonization in Iranian Human Immunodeficiency Virus positive patients. J Mycol Med 2010; 20(1): 8-14.
  12. Bougnoux ME, Morand S, d'Enfert C. Usefulness of multilocus sequence typing for characterization of clinical isolates of Candida albicans. J Clin Microbiol 2002; 40(4): 1290-7.
  13. National Committee for Clinical Laboratory Standards. Reference method for broth dilution testing of yeasts. Approved standard (M27-A2). 2nd ed. Wayne PA: National Committee for Clinical Laboratory Standards; 2002.
  14. Rex JH, Pfaller MA, Galgiani JN, Bartlett MS, Espinel-Ingroff A, Ghannoum MA, et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clin Infect Dis 1997; 24(2): 235-47.
  15. Matar MJ, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH. Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrob Agents Chemother 2003; 47(5): 1647-51.
  16. Riederer KM, Ramanathan J, Barczak J, Baran J, Jr., Khatib R. Utility of a pre-optimized kit for random amplified polymorphic DNA in typing Candida albicans. Can J Microbiol 2002; 48(4): 369-73.
  17. Kumar S, Tamura K, Jakobsen IB, Nei M. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 2001; 17(12): 1244-5.
  18. Vrioni G, Matsiota-Bernard P. Molecular typing of Candida isolates from patients hospitalized in an intensive care unit. J Infect 2001; 42(1): 50-6.
  19. Darce BM, Gonzalez A, Barnabe C, Larrouy G. First characterization of Candida albicans by random amplified polymorphic DNA method in Nicaragua and comparison of the diagnosis methods for vaginal candidiasis in Nicaraguan women. Mem Inst Oswaldo Cruz 2002; 97(7): 985-9.
  20. Soll DR. The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev 2000; 13(2): 332-70.
  21. Odds FC. Molecular phylogenetics and epidemiology of Candida albicans. Future Microbiol 2010; 5(1): 67-79.
  22. Chong PP, Lee YL, Tan BC, Ng KP. Genetic relatedness of Candida strains isolated from women with vaginal candidiasis in Malaysia. J Med Microbiol 2003; 52(Pt 8): 657-66.
  23. Fahami S, Kordbacheh P, Moazeni M, Mahmoodi M, Mirhendi H. Species identification and strain typing of candida isolates by PCR-RFLP and RAPD-PCR analysis for determining the probable sources of nosocomial infections. Iran Red Crescent Med J 2010; 12(5): 539-47.
  24. Pinto PM, Resende MA, Koga-Ito CY, Tendler M. Genetic variability analysis among clinical Candida spp. isolates using random amplified polymorphic DNA. Mem Inst Oswaldo Cruz 2004; 99(2): 147-52.
  25. Fanello S, Bouchara JP, Jousset N, Delbos V, LeFlohic AM. Nosocomial Candida albicans acquisition in a geriatric unit: epidemiology and evidence for person-to-person transmission. J Hosp Infect 2001; 47(1): 46-52.
  26. Costa F, Manaia CM, Figueiral MH, Pinto E. Genotypic analysis of Candida albicans isolates obtained from removable prosthesis wearers. Lett Appl Microbiol 2008; 46(4): 445-9.
  27. Bautista-Munoz C, Boldo XM, Villa-Tanaca L, Hernandez-Rodriguez C. Identification of Candida spp. by randomly amplified polymorphic DNA analysis and differentiation between Candida albicans and Candida dubliniensis by direct PCR methods. J Clin Microbiol 2003; 41(1): 414-20.
  28. Meyer W, Maszewska K, Sorrell TC. PCR fingerprinting: a convenient molecular tool to distinguish between Candida dubliniensis and Candida albicans. Med Mycol 2001; 39(2): 185-93.
  29. Welsh J, McClelland M. Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res 1990; 18(24): 7213-8.
  30. Caetano-Anolles G. Amplifying DNA with arbitrary oligonucleotide primers. PCR Methods Appl 1993; 3(2): 85-94.
Journal of Isfahan Medical School
Volume 31, Issue 270 - Serial Number 270
November and December 2014
Pages 2362-2372

Files

History

  • Receive Date: 08 September 2013
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics